ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD phase 2a trial topline results
|
|
moneydown
|
130 |
58K |
16 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
130
|
58K
|
16
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
moneydown
|
67 |
24K |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
67
|
24K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
moneydown
|
50 |
15K |
1 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
50
|
15K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
moneydown
|
26K |
13M |
10 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
26K
|
13M
|
10
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half-Yearly Report Results
|
|
moneydown
|
18 |
5.6K |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
18
|
5.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma... Hong-Kong
|
|
moneydown
|
10 |
6.2K |
1 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
10
|
6.2K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
moneydown
|
45 |
16K |
0 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
45
|
16K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Momentum & Belief
|
|
moneydown
|
48 |
23K |
3 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
48
|
23K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
moneydown
|
23 |
8.4K |
0 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
23
|
8.4K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil TGA regulatory update
|
|
moneydown
|
39 |
25K |
2 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
39
|
25K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
The dawn of OSL
|
|
moneydown
|
22 |
14K |
2 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
22
|
14K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
where's the news on this??
|
|
moneydown
|
123 |
41K |
2 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
123
|
41K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
moneydown
|
34 |
19K |
2 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
34
|
19K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Media
|
|
moneydown
|
18 |
13K |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
18
|
13K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
moneydown
|
159 |
55K |
9 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
159
|
55K
|
9
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Termination of Mr Daniel Kenny as Chief Executive Officer
|
|
moneydown
|
64 |
44K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
64
|
44K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
moneydown
|
159 |
55K |
4 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
159
|
55K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
CEO Interview
|
|
moneydown
|
14 |
2.2K |
0 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
14
|
2.2K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW announces two clinical trials & launches capital raising
|
|
moneydown
|
36 |
10K |
7 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
36
|
10K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
moneydown
|
126 |
50K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
126
|
50K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
moneydown
|
108 |
31K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
108
|
31K
|
1
|
|
ASX - By Stock
|
ACW |
cortisol COVID
|
|
moneydown
|
0 |
430 |
4 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
0
|
430
|
4
|
|
ASX - By Stock
|
ACW |
Re:
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
|
|
moneydown
|
80 |
28K |
4 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
80
|
28K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
|
|
moneydown
|
80 |
28K |
3 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
80
|
28K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil receives Singapore regulatory approval
|
|
moneydown
|
14 |
7.9K |
9 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
14
|
7.9K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
|
|
moneydown
|
80 |
28K |
8 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
80
|
28K
|
8
|
|
ASX - By Stock
|
OSL |
Re:
EOY Target
|
|
moneydown
|
16 |
6.6K |
0 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
16
|
6.6K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Presentation at AAT-ADPD International Congress
|
|
moneydown
|
15 |
6.1K |
5 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
15
|
6.1K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Vienna AAT-AD/PD™ 2020 conference and COVID-19
|
|
moneydown
|
44 |
20K |
1 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Is MYX a bargain
|
|
moneydown
|
2.5K |
2.2M |
2 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
2.5K
|
2.2M
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
moneydown
|
89 |
1.5M |
6 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
89
|
1.5M
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
moneydown
|
89 |
1.5M |
7 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
89
|
1.5M
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
moneydown
|
89 |
1.5M |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
89
|
1.5M
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Is MYX a bargain
|
|
moneydown
|
2.5K |
2.2M |
0 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
2.5K
|
2.2M
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Is MYX a bargain
|
|
moneydown
|
2.5K |
2.2M |
0 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
2.5K
|
2.2M
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4C - quarterly
|
|
moneydown
|
43 |
36K |
0 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
43
|
36K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4C - quarterly
|
|
moneydown
|
43 |
36K |
4 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
43
|
36K
|
4
|
|
ASX - By Stock
|
MYX Medicine |
Re:
New Product Approvals
|
|
moneydown
|
225 |
297K |
7 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
225
|
297K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
moneydown
|
395 |
274K |
4 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
395
|
274K
|
4
|
|
ASX - By Stock
|
ACW |
Coronavirus and cortisol
|
|
moneydown
|
7 |
16K |
4 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
7
|
16K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
moneydown
|
395 |
274K |
1 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
395
|
274K
|
1
|
|
ASX - By Stock
|
OLL |
Re:
I just did a course on OpenLearning
|
|
moneydown
|
33 |
15K |
0 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
33
|
15K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
moneydown
|
395 |
274K |
1 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
395
|
274K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
moneydown
|
53 |
30K |
8 |
19/01/20 |
19/01/20 |
ASX - By Stock
|
53
|
30K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
2 months no news
|
|
moneydown
|
45 |
16K |
7 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
45
|
16K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Positive CE Mark Status Report
|
|
moneydown
|
161 |
84K |
2 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
161
|
84K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Managing Director's AGM Presentation
|
|
moneydown
|
89 |
33K |
0 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
89
|
33K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: 2019 AGM CEO's Speech
|
|
moneydown
|
174 |
101K |
5 |
22/11/19 |
22/11/19 |
ASX - By Stock
|
174
|
101K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: 2019 AGM CEO's Speech
|
|
moneydown
|
174 |
101K |
4 |
22/11/19 |
22/11/19 |
ASX - By Stock
|
174
|
101K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
moneydown
|
210 |
84K |
9 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
210
|
84K
|
9
|
|